BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

AmpliMed Corporation 

4380 N. Campbell Avenue
Suite 205
Tucson  Arizona  85718  U.S.A.
Phone: 520-529-1000 Fax: 520-529-3001


SEARCH JOBS


Industry
Pharmaceutical






 Company News
AmpliMed Corporation Reports Results from AMP-019; A Randomized Double Blind Trial of Gemcitabine/Placebo vs. Gemcitabine/Amplimexon in Advanced Pancreatic Cancer 7/12/2010 10:44:11 AM    More...
AmpliMed Corporation Announces License Agreement with Handok Pharmaceuticals for Exclusive Rights to Cancer Therapeutic Amplimexon(R) in Korea 9/10/2008 6:26:38 AM    More...
AmpliMed Corporation to Present Clinical Data from Three Clinical Trials of Amplimexon® at American Society of Clinical Oncology Annual Meeting 5/30/2008 10:19:43 AM    More...
AmpliMed Corporation Announces Start of Randomized Phase 2 Trial of Amplimexon in Pancreatic Cancer 5/1/2008 10:13:29 AM    More...
AmpliMed Corporation Secures $8.5M In Additional Series B Financing; Oncology Drug Development Company To Use Funds To Achieve Milestones In Clinical Development 11/28/2006 9:58:47 AM    More...
AmpliMed Corporation To Present Positive Phase I Study Results For Amplimexon(R) (imexon for inj.) In Patients With Advanced Solid Tumors 11/10/2006 10:26:00 AM    More...
AmpliMed Corporation Announces Interim Phase I/II Trial Results For Amplimexon Plus Dacarbazine For Treatment Of Malignant Melanoma 9/14/2006 2:09:42 PM    More...
AmpliMed Corporation Announces Interim Phase I/II Trial Results For Amplimexon plus Dacarbazine For Treatment Of Malignant Melanoma; Encouraging Data Presented At Perspectives In Melanoma X And The Third International Melanoma Research Congress In The Netherlands 9/14/2006 9:57:50 AM    More...
AmpliMed Corporation Initiates Phase I Clinical Study Of Benzimate In Patients With Advanced Refractory Cancer 4/28/2006 1:18:10 PM    More...
AmpliMed Corporation Begins Enrollment Of Phase I Trial Of Amplimexon In Patients With Multiple Myeloma 3/28/2006 12:29:26 PM    More...
123

//-->